Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

250
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
250
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

532
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
532
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

259
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
259
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

833
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
833
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

414
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
414
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

412
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
412

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PDA (Privacy-Preserving Distributed Algorithms) in action: ten principles for high-quality multi-site clinical evidence generation.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Nonparametric Density Estimation of a Long-Term Trend from Repeated Semicontinuous Data.

Journal of the American Statistical Association·2026
Same author

Generative AI-assisted Bayesian-frequentist Hybrid Inference in Single-cell RNA Sequencing Analysis for Genes Associated with Alzheimer's Disease.

medRxiv : the preprint server for health sciences·2026
Same author

Application of the Total Nutrient Index as a Precision Nutrition Tool to Address Dietary Recommendations Across the Life Course.

Journal of the Academy of Nutrition and Dietetics·2026
Same author

<i>BLRM-EffTox</i>: A seamless two-stage phase 1 Bayesian logistic regression design incorporating efficacy-toxicity trade-off for dose optimization.

Journal of biopharmaceutical statistics·2026
Same author

Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses-Application to Phase III Trial.

Statistics in medicine·2025

Related Experiment Video

Updated: Nov 26, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.8K

Integration of Survival and Binary Data for Variable Selection and Prediction: A Bayesian Approach.

Arnab Kumar Maity1, Raymond J Carroll2, Bani K Mallick3

  • 1Early Clinical Development Oncology Statistics, 10777 Science Center Drive, Pfizer Inc., San Diego, CA 92121.

Journal of the Royal Statistical Society. Series C, Applied Statistics
|December 14, 2020
PubMed
Summary

This study identifies key proteins affecting both cancer survival and stage by integrating diverse genomic data. The novel Bayesian model enhances cancer survival prediction accuracy using high-dimensional protein data.

Keywords:
AFT modelHigh dimensional shrinkageProbit modelProtein expressionThe Cancer Genome Atlashorseshoe prior

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K

Related Experiment Videos

Last Updated: Nov 26, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.8K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K

Area of Science:

  • Genomics
  • Biostatistics
  • Cancer Research

Background:

  • Cancer data integration presents challenges in identifying shared predictive factors.
  • The Cancer Genomic Atlas (TCGA) offers rich survival and protein expression data.
  • Existing models may not effectively leverage multi-omics data for joint prediction.

Purpose of the Study:

  • To develop a statistical model for selecting common predictors of cancer survival and stage.
  • To build an integrated survival prediction model using high-dimensional protein data.
  • To identify actionable proteins influencing both cancer outcomes and progression.

Main Methods:

  • A Bayesian hierarchical model was developed to jointly analyze survival time and cancer stage.
  • Shrinkage priors were employed to handle high-dimensional Reverse-phase Protein Array (RPPA) data.
  • The model was validated using simulations and TCGA data.

Main Results:

  • The joint integrated modeling approach demonstrated improved survival prediction.
  • Significant proteins affecting both survival and cancer stage were identified.
  • The method effectively addressed the high dimensionality of RPPA measurements.

Conclusions:

  • Joint modeling of survival and cancer stage improves prediction accuracy.
  • This approach facilitates the identification of key proteins in cancer progression.
  • Data integration and advanced statistical methods are crucial for cancer research.